This recorded webinar reviews the clinical use of cResponse, a solid tumour functional testing platform based on ex-vivo organ cultures. The speakers discuss how cResponse can be used to assess treatment sensitivity and resistance, with a focus on real-world application.
The session includes an overview of the cResponse platform, clinical use cases, and expert discussion with Professor Ravid Straussman, Dr Jonathan Krell, and chair Professor Tobi Arkneau.’
